XML 44 R32.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Schedule of Class A Common Stock Available for Future Issuance
The Company had reserved the following shares of Class A common stock for future issuance:
(in thousands)
As of December 31,20222021
Shares outstanding from stock options and restricted stock units13,51710,261
Shares available for future equity award grants7,5543,679
Shares available for future ESPP offerings201841
Total shares reserved21,27214,781
Schedule of Stock Options Roll Forward
A summary of the Company’s stock option activity for its Plans is as follows:
Outstanding
Stock
Options
(in thousands)
Weighted
Average
Exercise
Price
Weighted
Average
Contractual
Life
(Years)
Aggregate Intrinsic Value
(in millions)
Balance as of December 31, 2021
6,443 $8.84 6.5$45.3 
Granted1,324 $10.70 
Exercised(1,346)$5.93 
Cancelled/forfeited(309)$10.38 
Balance as of December 31, 2022
6,112 $9.81 6.7$11.9 
Vested and exercisable as of December 31, 2022
3,861 $8.03 5.6$11.2 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The per-share fair value of each stock option was determined on the date of grant using the following weighted-average assumptions and ranges of fair value of common stock:
Year Ended December 31,202220212020
Expected volatility52.5 %53.7 %52.2 %
Expected term (in years)6.06.06.1
Expected dividend yield%%%
Risk-free interest rate2.6 %1.1 %0.6 %
Schedule of Outstanding Nonvested RSUs
A summary of the Company’s outstanding nonvested RSUs for its Plans is as follows:
Number of Units
(in thousands)
Weighted-Average
Grant Date Fair Value
Nonvested as of December 31, 2021
3,818 $18.07 
Granted6,416 $10.47 
Vested(1,521)$16.12 
Forfeited(1,308)$15.65 
Nonvested as of December 31, 2022
7,405 $12.27 
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions
The fair value of purchase rights granted under the ESPP were determined on the date of grant using the following weighted-average assumptions:
Year Ended December 31,20222021
Expected volatility59.6 %49.8 %
Expected term (in years)1.01.4
Expected dividend yield%%
Risk-free interest rate2.8 %0.4 %
Schedule of Stock-based Compensation Expense The Company recognized stock-based compensation under the Plans and ESPP as follows:
(in millions)
Year Ended December 31,202220212020
Research and development$12.0 $6.8 $3.1 
Sales and marketing12.4 5.8 1.9 
General and administrative10.0 5.3 1.4 
Total$34.4 $17.9 $6.4